Robert Paul Harris Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert Paul Harris.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert Paul Harris. Robert Paul Harris is Chief Executive Officer in Tribute Pharmaceuticals Canada Inc. ($SLRXF) and President & CEO in Tribute Pharmaceuticals Canada Inc. ($SLRXF) and Director in Aralez Pharmaceuticals Inc. ($ARLZ).
Latest Insider Trading Transactions of Robert Paul Harris
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Option Exercise | A | 1.56 | 15,000 | 23,400 | 15,000 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Grant | A | 0.00 | 7,500 | 0 | 601,594 | 594.1 K to 601.6 K (+1.26 %) |
| Nov 30 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Option Exercise | M | 3.92 | 104,778 | 410,730 | 0 | |
| Nov 30 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Option Exercise | M | 3.92 | 20,000 | 78,400 | 104,778 | |
| Nov 30 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Sell | S | 4.99 | 104,778 | 523,146 | 594,094 | 698.9 K to 594.1 K (-14.99 %) |
| Nov 30 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Buy | M | 3.92 | 104,778 | 410,730 | 698,872 | 594.1 K to 698.9 K (+17.64 %) |
| Nov 30 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Sell | S | 4.65 | 20,000 | 93,000 | 594,094 | 614.1 K to 594.1 K (-3.26 %) |
| Nov 30 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Buy | M | 3.92 | 20,000 | 78,400 | 614,094 | 594.1 K to 614.1 K (+3.37 %) |
| Sep 19 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Sell | S | 6.04 | 75,000 | 453,218 | 594,094 | 669.1 K to 594.1 K (-11.21 %) |
| Sep 19 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Sell | S | 5.60 | 75,000 | 420,000 | 669,094 | 744.1 K to 669.1 K (-10.08 %) |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Option Exercise | A | 3.42 | 15,000 | 51,300 | 15,000 | |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Grant | A | 0.00 | 7,500 | 0 | 744,094 | 736.6 K to 744.1 K (+1.02 %) |
| Mar 31 2014 | SLRXF | Tribute Pharmaceut ... | Harris Robert Paul | President & CEO | Option Exercise | D | 0.56 | 172,454 | 96,574 | 1,141,514 | |
| Mar 31 2014 | SLRXF | Tribute Pharmaceut ... | Harris Robert Paul | President & CEO | Option Exercise | A | 0.36 | 189,617 | 68,262 | 1,314,343 | |
| Jun 26 2013 | SLRXF | Tribute Pharmaceut ... | Harris Robert Paul | President & CEO | Option Exercise | A | 0.40 | 90,000 | 36,000 | 1,124,276 | |
| Mar 20 2013 | SLRXF | Tribute Pharmaceut ... | Harris Robert Paul | Chief Executive Off ... | Option Exercise | P | 0.60 | 312,500 | 187,500 | 625,000 | |
| Mar 20 2013 | SLRXF | Tribute Pharmaceut ... | Harris Robert Paul | Chief Executive Off ... | Option Exercise | P | 0.50 | 312,500 | 156,250 | 312,500 | |
| Mar 20 2013 | SLRXF | Tribute Pharmaceut ... | Harris Robert Paul | Chief Executive Off ... | Buy | P | 0.40 | 625,000 | 250,000 | 8,875,000 | 8.3 M to 8.9 M (+7.58 %) |
| Mar 20 2013 | SLRXF | Tribute Pharmaceut ... | Harris Robert Paul | Chief Executive Off ... | Buy | P | 0.56 | 550,000 | 308,000 | 8,250,000 | 7.7 M to 8.3 M (+7.14 %) |
| Mar 20 2013 | SLRXF | Tribute Pharmaceut ... | Harris Robert Paul | Chief Executive Off ... | Buy | P | 0.56 | 550,000 | 308,000 | 7,700,000 | 7.2 M to 7.7 M (+7.69 %) |
Page: 1